GPCR Structure Therapeutics Inc.

NASDAQ
$35.93

Structure Therapeutics Inc. (GPCR) is expected to report earnings on November 11, 2026, after the market close. The consensus earnings estimate is a loss of $0.51 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -33.2% since its last earnings release on August 6, 2026.

Structure Therapeutics Missed Consensus Estimates
Thursday, August 6, 2026 · 4:05 PM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 11
Wednesday · 4:05 PM ET
Earnings Whisper
-
vs ($0.51)
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP $43.65

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Structure Therapeutics Inc.

Structure Therapeutics Inc. is a clinical-stage global biopharmaceutical company discovering and developing novel oral therapeutics to treat chronic metabolic and pulmonary diseases with unmet medical needs. Structure Therapeutics Inc. is based in SAN FRANCISCO.

Sector

Healthcare

Industry

Biotechnology

Held By 4 ETFs, by dollar flow

Charts powered in part by Lightweight Charts™ by TradingView.